Novartis touts Arzerra's CLL study results; Teva taps former Israeli president as consultant; Richter med gets EU backing;

@FiercePharma: Figo launches new pet insurance plans amid booming market. FierceAnimalHealth story | Follow @FiercePharma

@EricPFierce: Lilly's Elanco unloading Novartis California vax plant it picked up in animal health deal. FiercePharmaManufacturing report | Follow @EricPFierce

@CarlyHFierce: Mylan Board Unanimously Rejects Unsolicited Expression of Interest from Teva. Release | Follow @CarlyHFierce

> Novartis ($NVS) said its blood cancer drug Arzerra hit its goal in a Phase III study in relapsed patients with chronic lymphocytic leukemia (CLL). Release

> Former Israeli President Shimon Peres has signed on as a consultant at Teva Pharmaceutical ($TEVA), planning to donate his $10,000-per-month pay to charity. Report

> A gynecological drug from Hungary-based Richter, Esmya, won a European recommendation for long-term use against uterine fibroid symptoms. Report

> The U.S. Supreme Court is set to hear arguments over a drug the state of Oklahoma used in executions after the usual injections ran scarce. Report

> Brazilian drugmaker Hypermarcas posted flat profits for the first quarter, as higher sales were offset by higher costs. Report

> Moberg Pharma bought Balmex brand over-the-counter products in the U.S. for $3.9 million. Report

Medical Device News

@FierceMedDev: ICYMI from FierceDiagnostics: Veracyte unveils $40M private placement to generate cash for R&D. Article | Follow @FierceMedDev

@VarunSaxena2: ICYMI: Updated w/ $MDT comment: Medtronic facing new wrongful death lawsuit over failed insulin pump in wake of 2009 recall. More | Follow @VarunSaxena2

@EmilyWFierce: Neuronetics raised $34.3M in a Series F round led by $GE for noninvasive magnetic stimulation device for depression. More from the WSJ | Follow @EmilyWFierce

> Sorin Group touts study showing its flexible implant for mitral valve disease is better than Medtronic's. More

> Spectranetics shares slump as the medical laser maker snips forecast. Story

> Boston Scientific loses bid to throw out claims tied to vaginal mesh device. Report

Biotech News

@FierceBiotech: Biogen partner Sobi and its Boston-based CEO field a takeover bid. News | Follow @FierceBiotech

@JohnCFierce: No, $BLUE is not $CLDN. Not hard to separate these companies' technology/pipelines. | Follow @JohnCFierce

@DamianFierce: tal im' oh jeen la her" pa rep' vek. Amgen file | Follow @DamianFierce

> FDA review challenges Amgen on a questionable T-Vec study. Story

> Synta CEO bolts after less than a year, leaving a biotech on the mend. News

> Celgene bags a build-to-buy biotech in $485M cancer deal. Report

Animal Health News

> Bayer closes MO animal health plant, citing excess capacity. News

> New study warns you can catch diseases from your pets. Story

> Lilly beats estimates on newly bulked-up animal health unit. Item

> Fallout continues in wake of avian bird flu spreading across the U.S. More

> Dog data at AACR cancer confab may point to personalized treatments. Report

Biotech IT News

> Quest, LabCorp team to build database of cancer genetics. News

> Edico and Intel set sights on real-time whole genome analysis. More

> Lilly, Novartis and Pfizer give trial-patient matching tech to TrialReach. Report

> WuXi invests $15M in DNAnexus to fuel push into China. Story

> AstraZeneca tightens ties to Roche's informatics platform provider. Article

And Finally... U.S. scientists are scrambling to gain understanding of newly emergent avian flu viruses. Report

Suggested Articles

Belén Garijo, currently CEO of Merck Healthcare, will succeed Stefan Oschmann as the German company's chief exec when his tenure ends in April 2021.

More than 60 researchers and bioethicists called on Pfizer to take time to collect more COVID-19 vaccine safety data, Bloomberg reports. 

Leaked details about an ad campaign to quell coronavirus fears before the election raise "every red flag I could dream of," an ex-HHS official said.